It was a delight to be able to speak with Prof. Maria Paola Costi (University of Modena and Reggio Emilia Via Campi, Modena, Italy) about recent discoveries being made in the treatment of visceral leishmaniasis. Her talk entitled ‘Visceral leishmaniasis: the discovery & clinical landscape’ was presented at the ISNTD d3 2021 Virtual Congress, 24-25 February.
Questions
- Could you tell us a little about recent research into flavonol-like compounds with anti-leishmania activity? (0:20)
- What is the potential of miltesofine analogs in the treatment of visceral leishmaniasis? and what is the current status of research? (2:35)
- Could you give us an overview of the NMTrypl project and its aims? (4:08)
Disclosures: Prof. Maria Paola Costi has nothing to disclose in relation to this video interview.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of ISNTD d3 2021 Virtual Conference.
